OPK compared with TXMD: revenue, margins and what each company keeps, and the suppliers and customers both name

OPKOpko Health, Inc.

Mkt capRevenueRevenue

TXMDTherapeuticsMD, Inc.

Mkt capRevenueRevenue

Compare

OPKOpko Health, Inc.

TXMDTherapeuticsMD, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OPK: latest quarter is a loss; flow not drawable. TXMD: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OPK 4

PFEPfizercustomer

ENTXEntera Biocustomer

—Nicoyaunlistedcustomer

—Vfmcrpunlistedcustomer

Shared 0

No disclosed counterparties: TXMD.

Only TXMD 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

OPK, solidTXMD, dashed

OPKOpko Health, Inc.

1.67▲+0.40%· post 1.65

Mkt cap$1.2BRevenue$164MQ2 FY26Revenue$607MFY25

TXMDTherapeuticsMD, Inc.

1.76▼−2.22%· post 1.80

ClosedOct 30 '26

Mkt cap$21.0MRevenue$869,000Q2 FY26Revenue$3MFY25

Compare

ClosedOct 30 '26

OPKOpko Health, Inc.

TXMDTherapeuticsMD, Inc.

1.67▲+0.40%post 1.65

Price

1.76▼−2.22%post 1.80

$1.2B

Mkt cap

$21.0M

Q2 FY26$164M

Revenue

$869,000Q2 FY26

FY25$607M

Revenue

$3MFY25

OPK1.67▲+0.40%vsTXMD1.76▼−2.22%ClosedOct 30 '26